Evidence for direct interactions between the NMDA and glycine recognition sites in brain.

Eur J Pharmacol

Nova Pharmaceutical Corporation, CNS Research, Baltimore, MD 21224-2788.

Published: March 1990

The interaction between glycine and competitive N-methyl-D-aspartate (NMDA) antagonists was investigated. Glycine (IC50 = 170 nM) partially (approximately 60%) inhibited [3H]CGS-19755 ((+/-)-4-phosphonomethyl-2-piperdine carboxylic acid), but not [3H]CPP (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) binding. The action of glycine was mimicked by D-serine and antagonized by 7-chlorokynurenate. CGS-19755 (IC50 = 230 nM) partially inhibited [3H]glycine binding from strychnine-insensitive sites; this effect was antagonized by NMDA. CPP and NPC 12626 (2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid) inhibited [3H]glycine binding, but only at concentrations 100- to 1000-fold greater than required to displace [3H]CGS-19755 or [3H]CPP. These data provide the first evidence for bidirectional interactions between glycine and NMDA recognition sites and suggest pharmacological differences among competitive NMDA antagonists.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0922-4106(90)90053-zDOI Listing

Publication Analysis

Top Keywords

recognition sites
8
nmda antagonists
8
inhibited [3h]glycine
8
[3h]glycine binding
8
nmda
5
glycine
5
evidence direct
4
direct interactions
4
interactions nmda
4
nmda glycine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!